Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence E Burgess

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Chemokines in allergyDavid Chantry, Laurence E Burgess
Expert Opinion on Emerging Drugs|March 11, 2005
Inflammation Research Association: 12th international conferenceDavid Chantry, Laurence E Burgess
Journal of Neuroimmunology|May 14, 2003
Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosisVivian Malamud, Ady Vaaknin, Oded Abramsky, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonistsShelley Allen, Bradley Newhouse, Aaron S Anderson, et al.
Future Medicinal Chemistry|November 13, 2013
5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptorPeter Bach, Jonas Boström, Kay Brickmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonistsBradley Newhouse, Shelley Allen, Benjamin Fauber, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2007
Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitorsC Todd Eary, Zachary S Jones, Robert D Groneberg, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral BioavailabilityErik J Hicken, Fred P Marmsater, Mark C Munson, et al.
Journal of Medicinal Chemistry|January 25, 2007
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activityDerin C D'Amico, Toshi Aya, Jason Human, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo ActivityJay B Fell, John P Fischer, Brian R Baer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Chemokines in allergyDavid Chantry, Laurence E Burgess
Expert Opinion on Emerging Drugs|March 11, 2005
Inflammation Research Association: 12th international conferenceDavid Chantry, Laurence E Burgess
Journal of Neuroimmunology|May 14, 2003
Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosisVivian Malamud, Ady Vaaknin, Oded Abramsky, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonistsShelley Allen, Bradley Newhouse, Aaron S Anderson, et al.
Future Medicinal Chemistry|November 13, 2013
5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptorPeter Bach, Jonas Boström, Kay Brickmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonistsBradley Newhouse, Shelley Allen, Benjamin Fauber, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2007
Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitorsC Todd Eary, Zachary S Jones, Robert D Groneberg, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral BioavailabilityErik J Hicken, Fred P Marmsater, Mark C Munson, et al.
Journal of Medicinal Chemistry|January 25, 2007
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activityDerin C D'Amico, Toshi Aya, Jason Human, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo ActivityJay B Fell, John P Fischer, Brian R Baer, et al.
Pageof 2